Comparison of the bacterial HelA protein to the F508 region of the cystic fibrosis transmembrane regulator

被引:2
|
作者
Goldman, BS [1 ]
Sherman, DA [1 ]
Kranz, RG [1 ]
机构
[1] WASHINGTON UNIV, DEPT BIOL, ST LOUIS, MO 63130 USA
关键词
D O I
10.1128/jb.179.24.7869-7871.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HelA protein of Rhodobacter capsulatus is the ATP-binding-cassette subunit of an exporter complex required for cytochrome c biogenesis. By primary sequence comparisons the F88 residue of HelA is similar to the F508 residue of the cystic fibrosis transmembrane regulator (CFTR) protein. Previous studies have established that CFTR F508 Delta or F508R proteins are defective but F508C is functional. Our results demonstrate that the HelA F88 mutants functionally mimic the phenotypes of known CFTR F508 mutants. The phenotypes of additional HelA mutants and the in vivo steady-state levels of these proteins are also reported.
引用
收藏
页码:7869 / 7871
页数:3
相关论文
共 50 条
  • [42] Delta F508 in cystic fibrosis: Willing but not able
    Southern, KW
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (03) : 278 - 282
  • [43] Restoration of function of the ΔF508 mutation in cystic fibrosis
    Rowan, Stephen
    THORAX, 2012, 67 (10) : 881 - 881
  • [44] ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma
    Dahl, M
    Tybjærg-Hansen, A
    Lange, P
    Nordestgaard, BG
    LANCET, 1998, 351 (9120): : 1911 - 1913
  • [45] Overweight and obesity in ΔF508 homozygous cystic fibrosis
    Kastner-Cole, D
    Palmer, CNA
    Ogston, SA
    Mehta, A
    Mukhopadhyay, S
    JOURNAL OF PEDIATRICS, 2005, 147 (03): : 402 - 404
  • [46] F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review
    Yang, Hong
    Ma, Tonghui
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (09) : 991 - 1002
  • [47] ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis
    Kälin, N
    Claass, A
    Sommer, M
    Puchelle, E
    Tümmler, B
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10): : 1379 - 1389
  • [48] Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the ΔF508 mutation.: F508 deletion disrupts a kinase-binding site (Retraction of vol 282, pg 10804, 2007)
    Treharne, Kate J.
    Crawford, Russell M.
    Xu, Zhe
    Chen, Jeng-Haur
    Best, O. Giles
    Schulte, Eva A.
    Gruenert, Dieter C.
    Wilson, Stuart M.
    Sheppard, David N.
    Kunzelmann, Kar
    Mehta, Anil
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) : 25103 - 25103
  • [49] A Delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo
    French, PJ
    vanDoorninck, JH
    Peters, RHPC
    Verbeek, E
    Ameen, NA
    Marino, CR
    deJonge, HR
    Bijman, J
    Scholte, BJ
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06): : 1304 - 1312
  • [50] Interleukin 8 secretion from monocytes of subjects heterozygous or the ΔF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered
    Zaman, MM
    Gelrud, A
    Junaidi, O
    Regan, MM
    Warny, M
    Shea, JC
    Kelly, C
    O'Sullivan, BP
    Freedman, SD
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (05) : 819 - 824